胸主动脉腔内修复术在胸主动脉疾病管理中的临床影响
该描述性研究回顾性分析了2012至2022年间接受胸主动脉腔内修复术(TEVAR)的66例胸主动脉疾病患者,平均年龄69.24岁,男性占60.61%。30天死亡率为10.61%,再干预率为21.21%。术中失血量增加(p=0.001)和男性(p=0.04)与死亡率有统计学关联。体重不足患者并发症风险为较高体重指数者的6.7倍(p=0.04,95%CI=0.82-7.21),内漏风险为11.4倍(p=0.02,95%CI=1.31-12.57)。作者认为TEVAR似乎是胸主动脉病变患者的可行选择,体重不足患者似乎总体并发症和内漏风险增加,需进一步前瞻性研究证实。
要点
- 66例TEVAR患者30天死亡率为10.61%,再干预率为21.21%。
- 术中失血量增加(p=0.001)和男性(p=0.04)与死亡率有统计学关联。
- 体重不足患者并发症风险为较高体重指数者的6.7倍(95%CI=0.82-7.21),内漏风险为11.4倍(95%CI=1.31-12.57)。
核心结论
- 胸主动脉腔内修复术似乎是胸主动脉病变患者的可行选择,死亡率和并发症率可接受。
- 体重不足患者似乎总体并发症风险增加且内漏风险增加。
- 需要进一步前瞻性研究证实作者的结果。
研究设计与样本
- 描述性研究,基于前瞻性收集数据库的回顾性综述。
- 纳入2012年至2022年间接受TEVAR的年龄大于18岁的患者,共66例。
- 描述了患者人口学特征、围手术期数据、手术结局、并发症和死亡率,并进行了统计和多变量分析,p值小于0.05认为有统计学意义。
主要发现
- 男性患者占60.61%,平均年龄69.24岁。
- 相关主动脉疾病为动脉瘤(68.18%)、溃疡相关(4.55%)、壁内血肿相关(7.58%)、创伤相关病理(1.52%)和主动脉夹层(30.30%)。
- 平均住院时间为18.10天,98.48%需要重症监护。
- 30天死亡率为10.61%,再干预率为21.21%。
- 术中失血量增加(p=0.001)和男性(p=0.04)与死亡率有统计学关联。
临床怎么用
- 作者认为胸主动脉腔内修复术似乎是胸主动脉病变患者的可行选择,死亡率和并发症率可接受。
- 作者认为体重不足患者似乎总体并发症风险增加且内漏风险增加。
- 作者建议需要进一步前瞻性研究证实其结果表明肥胖和体重指数不应被视为该手术术后并发症和死亡率的高风险特征。
局限性
- 原文报告需要进一步前瞻性研究证实作者的结果。
- 原文报告体重不足患者并发症风险95%CI=0.82-7.21,内漏风险95%CI=1.31-12.57。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Thoracic endovascular aortic repair (TEVAR) has been described to be superior to an open surgical approach, and previous studies have found superiority in TEVAR by reducing overall morbidity and mortality rates. This study aimed to describe the outcomes of TEVAR for patients with thoracic aortic disease at a high complexity. MATERIALS AND METHODS: Descriptive study, developed by a retrospective review of a prospectively collected database. Patients aged above 18 years who underwent TEVAR between 2012 and 2022 were included. Patient demographics, perioperative data, surgical outcomes, morbidity, and mortality were described. Statistical and multivariate analyses were made. Statistical significance was reached when p values were <0.05. RESULTS: A total of 66 patients were included. Male patients were 60.61% and the mean age was 69.24 years. Associated aortic diseases were aneurysms (68.18%), ulcer-related (4.55%), intramural-related hematoma (7.58%), trauma-related pathology (1.52%), and aortic dissection (30.30%). The mean hospital stay was 18.10 days, and intensive care unit was required for 98.48%. At 30 days, the mortality rate was 10.61% and the reintervention rate was 21.21%. Increased intraoperative blood loss (p=0.001) and male sex (p=0.04) showed statistical relationship with mortality. Underweight patients have 6.7 and 11.4 times more risk of complications and endoleak compared with higher body mass index values (p=0.04, 95% confidence interval [CI]=0.82-7.21) and (p=0.02, 95% CI=1.31-12.57), respectively. CONCLUSION: Thoracic endovascular aortic repair seems to be a feasible option for patients with thoracic aortic pathologies, with adequate rates of mortality and morbidity. Underweight patients seem to have an increased risk of overall morbidity and increased risk for endoleak. Further prospective studies are needed to prove our results. CLINICAL IMPACT: Obesity and BMI are widely studied in the surgical literature. According to our study, there is a paradox regarding the outcomes of patients treated with TEVAR in terms of postoperative complications and mortality related to the body mass index. And shouldn't be considered as a high-risk feature in terms of postoperative morbidity and mortality in this procedure.
引用
- Molano F, Rey Chaves CE, Conde D, et al. The Clinical Impact of Thoracic Endovascular Aortic Repair in the Management of Thoracic Aortic Diseases. J Endovasc Ther. 2023. PMID: 36609171. doi:10.1177/15266028221148381
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。